Journal of Chemotherapy

Papers
(The TQCC of Journal of Chemotherapy is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
A systematic review of implications, mechanisms, and stability of in vivo emergent resistance to colistin and tigecycline in Acinetobacter baumannii31
Managing adult patients with infectious diseases in emergency departments: international ID-IRI study23
Compliance with South Africa’s Antimicrobial Resistance National Strategy Framework: are we there yet?22
Effect of a “handshake” stewardship program versus a formulary restriction policy on High-End antibiotic use, expenditure, antibiotic resistance, and patient outcome19
Comparison of lorlatinib, alectinib and brigatinib in ALK inhibitor–naive/untreated ALK-positive advanced non-small-cell lung cancer: a systematic review and network meta-analysis17
Infective endocarditis by Acinetobacter species: a systematic review16
Infective endocarditis by Enterobacter cloacae: a systematic review and meta-analysis13
Roseomonasspecies infections in humans: a systematic review13
Current treatments for inoperable mesothelioma: indirect comparisons based on individual patient data reconstructed retrospectively from 4 trials12
Evaluation of efficacy and safety of fosfomycin versus nitrofurantoin for the treatment of uncomplicated lower urinary tract infection (UTI) in women – A systematic review and meta-analysis12
Differential effects of C-reactive protein levels on voriconazole metabolism at three age groups in allogeneic hematopoietic cell transplant recipients11
Activity of ceftolozane-tazobactam, ceftazidime-avibactam, meropenem-vaborbactam, cefiderocol and comparators against Gram-negative organisms causing bloodstream infections in Northern Italy (2019–20211
Anti-biofilm activity of dalbavancin against methicillin-resistant Staphylococcus aureus (MRSA) isolated from human bone infection11
Metformin induces myeloma cells necrosis and apoptosis and it is considered for therapeutic use11
Urinary tract infection in a human male patient with Staphylococcus pseudintermedius transmission from the family dog10
Epidemiology, prevalence and risk factors for infections in burn patients: results from a regional burn centre’s analysis10
Calcium-oxidative stress signaling axis and casein kinase 1α mediate eryptosis and hemolysis elicited by novel p53 agonist inauhzin10
miR-302a-3p suppresses melanoma cell progression via targeting METTL310
Therapeutic options for COVID-19: a quick review10
Gram-negative bacteria as causative agents of ventilator-associated pneumonia and their respective resistance mechanisms10
A plethora of carbapenem resistance inAcinetobacter baumannii: no end to a long insidious genetic journey10
Dalbavancin for infective endocarditis: a single centre experience9
The efficacy of colistin monotherapy versus combination therapy with other antimicrobials against carbapenem-resistant Acinetobacter baumannii ST2 isolates9
Investigation of anticancer activities of STA-9090 (ganetespib) as a second generation HSP90 inhibitor in Saos-2 osteosarcoma cells9
miR-4486 enhances cisplatin sensitivity of gastric cancer cells by restraining the JAK3/STAT3 signalling pathway9
Evaluation of the synergy of ceftazidime/avibactam in combination with colistin, doripenem, levofloxacin, tigecycline, and tobramycin against OXA-48 producing Enterobacterales9
Early 3-day course of remdesivir in vaccinated outpatients with SARS-CoV-2 infection. A success story9
CircRNA_001895 promotes sunitinib resistance of renal cell carcinoma through regulation of apoptosis and DNA damage repair9
Lopinavir/ritonavir as a third agent in the antiviral regimen for SARS-CoV-2 infection9
Efficacy and toxicity of adjuvant chemotherapy on colorectal cancer patients: how much influence from the genetics?8
Bacteremia with Staphylococcus pseudintermedius in a 4 month old pediatric oncology patient8
In-vitro activity of fosfomycin against Escherichia coli and Klebsiella pneumoniae bloodstream isolates and frequency of OXA-48, NDM, KPC, VIM, IMP types of carbapenemases 8
MiR-144-3p inhibits the proliferation, migration and invasion of lung adenocargen cancer cells by targeting COL11A18
Trabectedin-irinotecan, a potentially promising combination in relapsed desmoplastic small round cell tumor: report of two cases8
Prognostic factors and effect on survival of immune-related adverse events in patients with non-small-cell lung cancer treated with immune checkpoint blockage8
Hypocrellin B triggered sonodynamic therapy reverses multidrug resistance of doxorubicin-resistant SGC7901/ADR cells via down-regulation of P-gp expression8
Circ_0007841 knockdown confers cisplatin sensitivity to ovarian cancer cells by down-regulation of NFIB expression in a miR-532-5p-dependent manner7
Prognostic significance of sarcopenia and decreased relative dose intensity during the initial two cycles of first-line sunitinib for metastatic renal cell carcinoma7
Performance of capecitabine in novel combination therapies in colorectal cancer7
Influence of plasma methotrexate level and MTHFR genotype in Korean paediatric patients with acute lymphoblastic leukaemia7
Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients7
Voriconazole pharmacokinetics in a critically ill patient during extracorporeal membrane oxygenation7
Epidemiology and risk factors for healthcare-associated infections caused by Pseudomonas aeruginosa7
C1q-like 1 is frequently up-regulated in lung adenocarcinoma and contributes to the proliferation and invasion of tumor cells7
Infective endocarditis by Klebsiella species: a systematic review7
Ceftobiprole and pneumonia in adults admitted to the emergency department is it time to assess a new therapeutic algorithm?7
Relationship between renal dysfunction and electrolyte abnormalities in hematopoietic stem cell transplant patients treated with foscarnet7
Effect of remdesivir on mortality rate and clinical status of COVID-19 patients: a systematic review with meta-analysis6
Application of tumoroids derived from advanced colorectal cancer patients to predict individual response to chemotherapy6
Dissemination of VIM-producingPseudomonas aeruginosaassociated with high-risk clone ST654 in a tertiary and quaternary hospital in Makkah, Saudi Arabia6
Community-acquired pneumonia: aetiology, antibiotic resistance and prospects of phage therapy6
Lambert-Eaton myasthenic syndrome (LEMS) in a patient with lung cancer under treatment with pembrolizumab: a case study6
Factors affecting the mortality rate of patients with cancer hospitalized with COVID-19: a single center’s experience6
FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer6
Exploring metastatic breast cancer treatment changes during COVID-19 pandemic6
Endocarditis in kidney transplant recipients: a systematic review5
Efficacy and safety of intravenous fosfomycin for the treatment of carbapenem-resistant Klebsiella pneumoniae5
Successful treatment of persistent SARS-CoV-2 infection with nirmatrelvir/ritonavir plus sotrovimab in four immunocompromised patients5
Evaluation of fosfomycin combined with vancomycin against vancomycin-resistant coagulase negative staphylococci5
Risk of fatigue with PARP inhibitors in cancer patients: a systematic review and meta-analysis of 29 phase II/III randomized controlled trials5
Natural substances to potentiate canonical glioblastoma chemotherapy5
Capecitabine-associated enterocolitis: Narrative literature review of a rare adverse event and a case presentation5
Pediatric impetigo: an expert panel opinion about its main controversies5
Infective endocarditis in patients with liver cirrhosis: a systematic review5
Infective endocarditis by Serratia species: a systematic review5
Activity of cefiderocol and synergy of novel β-lactam-β-lactamase inhibitor-based combinations against metallo-β-lactamase-producing gram-negative bacilli: insights from a two-year study (2019–2020)5
LncRNA-SNHG1 promotes paclitaxel resistance of gastric cancer cells through modulating the miR-216b-5p-hexokianse 2 axis5
Knockdown of microRNA-203 reduces cisplatin chemo-sensitivity to osteosarcoma cell lines MG63 and U2OS in vitro by targeting RUNX25
Optimization of tigecycline dosage regimen for different infections in the patients with hepatic or renal impairment5
The point prevalence and inappropriateness of antibiotic use at hospitals in Turkey: a systematic review and meta-analysis5
Novel daidzein molecules exhibited anti-prostate cancer activity through nuclear receptor ERβ modulation, in vitro and in vivo studies5
Species distribution and antifungal susceptibilities of bloodstream Candida isolates: a nine-years single center survey5
Prevalence of leukoencephalopathy and its potential cognitive sequelae in cancer patients5
Initial trough concentration may be beneficial in preventing linezolid-induced thrombocytopenia5
Is pandrug-resistance in A. baumannii a transient phenotype? Epidemiological clues from a 4-year cohort study at a tertiary referral hospital in Greece4
Carbapenem-resistant Klebsiella pneumoniae outbreak in a COVID-19 intensive care unit; a case-control study4
Knockdown of METTL5 inhibits the Myc pathway to downregulate PD-L1 expression and inhibits immune escape of hepatocellular carcinoma cells4
Active metronomic vinorelbine schedules decrease plasma interleukin-2 levels in mice with Lewis lung carcinoma4
Outcomes of diagnosed COVID-19 cancer patients: concerning results of a systematic review4
Linezolid-related adverse effects in the treatment of rifampicin resistant tuberculosis: a retrospective study4
Pharmacodynamics of D-mannose in the prevention of recurrent urinary infections4
LncRNA-IQCH-AS1 sensitizes thyroid cancer cells to doxorubicin via modulating the miR-196a-5p/PPP2R1B signalling pathway4
Circulating tumour cells as prognosis predictive markers of neoadjuvant chemotherapy-treated breast cancer patients4
Looking beyond ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae: in vitro activity of the novel meropenem-vaborbactam in combination with the old fosfomycin4
Epidemiology, aetiology and treatment of skin and soft tissue infections: final report of a prospective multicentre national registry4
Proinflammatory circulating markers: new players for evaluating asymptomatic acute cardiovascular toxicity in breast cancer treatment4
Pegylated liposomal doxorubicin as first line treatment in aids-related Kaposi’s sarcoma: a real-life study4
Anlotinib as a post-third-line therapy for the treatment of advanced nonsmall cell lung cancer4
Dalbavancin treatment for spondylodiscitis: multi-center clinical experience and literature review4
Sorafenib for hepatocellular carcinoma: potential molecular targets and resistance mechanisms4
Comparative incidence of acute kidney injury in patients on vancomycin therapy in combination with cefepime, piperacillin-tazobactam or meropenem4
Negative impact of high body mass index on cetuximab-mediated cellular cytotoxicity against human colon carcinoma cells4
Circ_SETD3 regulates gefitinib sensitivity and tumor progression by miR-873-5p-dependent regulation of APPBP2 in non-small cell lung cancer4
Luteolin suppresses lung cancer progression through targeting the circ_0000190/miR-130a-3p/notch-1 signaling pathway4
0.027976989746094